Patent · US Active

Herpesvirus ribozymes and vectors

US7838659B2 · kind B2 · utility

0Cited by
1References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2008
Grant dateNov 23, 2010
Priority date
Expiry dateSep 11, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16622
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Hammerhead ribozymes that target components critical to HSV replication (ICP4, UL20, UL30, and UL54) were synthesized and shown to efficiently cleave target RNA encoding a portion of these components in in vitro assays. Several cloned cell lines stably expressing these ribozymes were established. HSV-mediated plaque formation was dramatically reduced in cells stably transfected with an anti-HSV ribozyme compared to non-transfected cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.